UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

Diabetes, obesity & metabolism, 2015-08, Vol.17 (8), p.742-750

2015

Volltextzugriff (PDF)

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

Diabetes, obesity & metabolism, 2015-08, Vol.17 (8), p.742-750

2015

Volltextzugriff (PDF)

Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes

Diabetes, obesity & metabolism, 2014-01, Vol.16 (1), p.57-62

2014

Volltextzugriff (PDF)

Clinical applicability of dOFM devices for dermal sampling

Skin research and technology, 2013-11, Vol.19 (4), p.474-483

2013

Volltextzugriff (PDF)

Ultra-Long Pharmacokinetic Properties of Insulin Degludec are Comparable in Elderly Subjects and Younger Adults with Type 1 Diabetes Mellitus

Drugs & aging, 2014-01, Vol.31 (1), p.47-53

2014

Volltextzugriff (PDF)

A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes

Diabetes, obesity & metabolism, 2013-03, Vol.15 (3), p.241-245

2013

Volltextzugriff (PDF)

Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursions

Diabetic medicine, 2010-03, Vol.27 (3), p.332-338

2010

Volltextzugriff (PDF)

Optimising the glucose sampling performance of an intravascular microdialysisbased continuous glucose monitoring device for use in hospital settings

Biomedizinische Technik, 2013-09, Vol.58 Suppl 1

2013

Volltextzugriff (PDF)

PaQ®, a simple 3-day basal/bolus insulin delivery device, in people with type 2 diabetes

Biomedizinische Technik, 2013-09, Vol.58 Suppl 1

2013

Volltextzugriff (PDF)

Certified dOFM sampling devices provide access to target tissue in pharmaceutical trials

Biomedizinische Technik, 2013-09, Vol.58 Suppl 1

2013

Volltextzugriff (PDF)

Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose Sensing

Biomedizinische Technik, 2013-09, Vol.58 Suppl 1

2013

Volltextzugriff (PDF)

The effect of exercise on the absorption of inhaled human insulin in healthy volunteers

British journal of clinical pharmacology, 2008-02, Vol.65 (2), p.165-171

2008

Volltextzugriff (PDF)

Subcutaneous glucose monitoring in patients with severe sepsis

Critical care (London, England), 2007, Vol.11 (Suppl 2), p.P144-P144

2007

Volltextzugriff (PDF)

Reduced local inflammatory reactivity in septic patients compared with healthy controls

Critical care (London, England), 2007, Vol.11 (Suppl 2), p.P21-P21

2007

Volltextzugriff (PDF)

Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2

PloS one, 2021-11, Vol.16 (11), p.e0259527-e0259527

2021

Volltextzugriff (PDF)

Effect of LiraglutideTreatment on Whole-body Glucose Fluxes in C-peptide-Positive Type 1 Diabetes During Hypoglycemia

The journal of clinical endocrinology and metabolism, 2022-09, Vol.107 (S1), p.e3583

2022

Volltextzugriff (PDF)

Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide–Positive Type 1 Diabetes During Hypoglycemia

The journal of clinical endocrinology and metabolism, 2022-09, Vol.107 (9), p.e3583-e3593

2022

Volltextzugriff (PDF)

The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes

Drugs & aging, 2015-07, Vol.32 (7), p.583-590

2015

Volltextzugriff (PDF)

Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM

The journal of clinical endocrinology and metabolism, 2018-04, Vol.103 (4), p.1408-1417

2018

Volltextzugriff (PDF)

Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

Diabetologia, 2014-01, Vol.57 (1), p.40-49

2014

Volltextzugriff (PDF)

Effect of once‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial

Diabetes, obesity & metabolism, 2018-11, Vol.20 (11), p.2565-2573

2018

Volltextzugriff (PDF)

Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling

European journal of pharmaceutics and biopharmaceutics, 2012-08, Vol.81 (3), p.635-641

2012

Volltextzugriff (PDF)

Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycaemia in T1D

The journal of clinical endocrinology and metabolism, 2018-02

2018

Volltextzugriff (PDF)

A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec

Clinical drug investigation, 2013-07, Vol.33 (7), p.515-521

2013

Volltextzugriff (PDF)

Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action

Journal of diabetes, 2016-01, Vol.8 (1), p.132-138

2016

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(86)
Berichte
(1)

Sprache

Englisch
(72)
Deutsch
(15)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(44)
Male
(36)
Humans
(29)
Female
(26)
Adult
(23)
Endocrinology & Metabolism
(20)
Animals
(18)
Biological And Medical Sciences
(18)
Middle Aged
(18)
Diabetes
(16)
Rats
(16)
Insulin
(15)
Medical Sciences
(14)
Glucose
(13)
Blood Glucose - Metabolism
(12)
Diabetes Mellitus, Type 1 - Drug Therapy
(12)
Rats, Inbred Strains
(11)
Aged
(10)
Pharmacology & Pharmacy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes

Clinical applicability of dOFM devices for dermal sampling

Ultra-Long Pharmacokinetic Properties of Insulin Degludec are Comparable in Elderly Subjects and Younger Adults with Type 1 Diabetes Mellitus

A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes

Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursions

Optimising the glucose sampling performance of an intravascular microdialysisbased continuous glucose monitoring device for use in hospital settings

PaQ®, a simple 3-day basal/bolus insulin delivery device, in people with type 2 diabetes

Certified dOFM sampling devices provide access to target tissue in pharmaceutical trials

Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose Sensing

The effect of exercise on the absorption of inhaled human insulin in healthy volunteers

Subcutaneous glucose monitoring in patients with severe sepsis

Reduced local inflammatory reactivity in septic patients compared with healthy controls

Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2

Effect of LiraglutideTreatment on Whole-body Glucose Fluxes in C-peptide-Positive Type 1 Diabetes During Hypoglycemia

Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide–Positive Type 1 Diabetes During Hypoglycemia

The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes

Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM

Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

Effect of once‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial

Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling

Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycaemia in T1D

A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec

Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action

Suchergebnisse filtern